37 related articles for article (PubMed ID: 18302259)
21. Prognostic significance of EGF receptor expression in early glottic cancer.
Demiral AN; Sarioglu S; Birlik B; Sen M; Kinay M
Auris Nasus Larynx; 2004 Dec; 31(4):417-24. PubMed ID: 15571917
[TBL] [Abstract][Full Text] [Related]
22. The role of epidermal growth factor receptor and E-cadherin for the outcome of reduction in the overall treatment time of radiotherapy of supraglottic larynx squamous cell carcinoma.
Eriksen JG; Steiniche T; Overgaard J;
Acta Oncol; 2005; 44(1):50-8. PubMed ID: 15848906
[TBL] [Abstract][Full Text] [Related]
23. An immunohistochemical study of cyclin D1 protein expression in laryngeal squamous cell carcinoma.
Morshed K; Skomra D; Korobowicz E; Szymański M; Polz-Dacewicz M; Gołabek W
Acta Otolaryngol; 2007 Jul; 127(7):760-9. PubMed ID: 17573573
[TBL] [Abstract][Full Text] [Related]
24. p53 and cyclin D1 as prognostic factors in squamous cell carcinoma of the larynx.
Vielba R; Bilbao J; Ispizua A; Zabalza I; Alfaro J; Rezola R; Moreno E; Elorriaga J; Alonso I; Baroja A; de la Hoz C
Laryngoscope; 2003 Jan; 113(1):167-72. PubMed ID: 12514403
[TBL] [Abstract][Full Text] [Related]
25. Association between high initial tissue levels of cyclin d1 and recurrence of nasopharyngeal carcinoma.
Lai JP; Tong CL; Hong C; Xiao JY; Tao ZD; Zhang Z; Tong WM; Betz CS
Laryngoscope; 2002 Feb; 112(2):402-8. PubMed ID: 11889405
[TBL] [Abstract][Full Text] [Related]
26. Molecular prognostic factors in adenocarcinoma of the esophagus and gastroesophageal junction.
Lagarde SM; ten Kate FJ; Richel DJ; Offerhaus GJ; van Lanschot JJ
Ann Surg Oncol; 2007 Feb; 14(2):977-91. PubMed ID: 17122988
[TBL] [Abstract][Full Text] [Related]
27. Expression of epidermal growth factor receptor and cyclin D1 in pretreatment biopsies as a predictive factor of radiotherapy efficacy in early glottic cancer.
Chang AR; Wu HG; Park CI; Jun YK; Kim CW
Head Neck; 2008 Jul; 30(7):852-7. PubMed ID: 18302259
[TBL] [Abstract][Full Text] [Related]
28. Molecular markers as prognostic factors for local recurrence and radioresistance in head and neck squamous cell carcinoma.
Smith BD; Haffty BG
Radiat Oncol Investig; 1999; 7(3):125-44. PubMed ID: 10406054
[TBL] [Abstract][Full Text] [Related]
29. Evidence-based review of treatment options for patients with glottic cancer.
Hartl DM; Ferlito A; Brasnu DF; Langendijk JA; Rinaldo A; Silver CE; Wolf GT
Head Neck; 2011 Nov; 33(11):1638-48. PubMed ID: 21990228
[TBL] [Abstract][Full Text] [Related]
30. Laryngeal tuberculosis following laryngeal carcinoma.
Nishiike S; Nagai M; Nakagawa A; Konishi M; Sakata Y; Aihara T; Harada T
J Laryngol Otol; 2006 Feb; 120(2):151-3. PubMed ID: 16359157
[TBL] [Abstract][Full Text] [Related]
31. Rationale for adjuvant fatty acid therapy to prevent radiotherapy failure and tumor recurrence during early laryngeal squamous cell carcinoma.
Louw L; Claassen J
Prostaglandins Leukot Essent Fatty Acids; 2008 Jan; 78(1):21-6. PubMed ID: 18054475
[TBL] [Abstract][Full Text] [Related]
32. Radioresistant laryngeal cancer: beyond the TNM stage.
Nix PA; Greenman J; Cawkwell L; Stafford N
Clin Otolaryngol Allied Sci; 2004 Apr; 29(2):105-14. PubMed ID: 15113291
[TBL] [Abstract][Full Text] [Related]
33.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
